The signal intensity of grade 0 cartilage was significantly greater than the intensities of grade 1, grade 2 or grade 3 cartilage (P < 0.001).
The signal intensity of grade 0 cartilage was significantly greater than the intensities of grade 1, grade 2 or grade 3 cartilage.
The myelosuppressive intensity of grade C chemotherapies that included remission induction therapy for acute leukemia was severe.
It was reported that 'signal intensity of grade 0 cartilage was significantly greater than those of grade 1, grade 2, or grade 3 cartilage'.
The signal intensity of grade 0 was greater at site B than at site E. The echo duration did not differ between the grades and between the sites.
The myelosuppressive intensity of grade B chemotherapies that included many different regimens (e.g. consolidation regimens for leukemia; CHOP, ABVD and ESHAP for malignant lymphoma) was moderate.
In the present study, the percentages of the signal intensity of grade 1, grade 2 and grade 3 cartilage to grade 0 cartilage were 48% (0.84 versus 1.74), 43% (0.75 versus 1.74) and 30% (0.53 versus 1.74), respectively.
For all other treatment-related adverse events with intensity of Grade 2 or higher (except Grade 3 peripheral neuropathy, severe fluid retention, hypersensitivity reactions, hepatic impairment or neutropenia, as described below), the following dose modification scheme was implemented.
Inter-rater agreement between the readers as to presence versus absence of a LAM test band with intensity of grade 2 cut-point was 99.1 % (kappa 0.94; SE 0.05).
In the present study, the signal intensity of grade 0 cartilage at site B was greater than that at site E. Cartilage at site B is located on the lateral condyle, and site E cartilage is located on the lateral tibial plateau exposed by the lateral meniscus.
